Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 26 studies | 43% ± 18% | |
fibroblast | 22 studies | 25% ± 8% | |
pericyte | 22 studies | 41% ± 15% | |
astrocyte | 19 studies | 44% ± 18% | |
mesothelial cell | 9 studies | 50% ± 25% | |
connective tissue cell | 8 studies | 25% ± 9% | |
type I pneumocyte | 7 studies | 26% ± 9% | |
myofibroblast cell | 7 studies | 35% ± 18% | |
epithelial cell | 5 studies | 42% ± 24% | |
ciliated cell | 5 studies | 40% ± 25% | |
GABAergic neuron | 4 studies | 20% ± 6% | |
abnormal cell | 4 studies | 38% ± 5% | |
Mueller cell | 4 studies | 39% ± 11% | |
neuron | 4 studies | 29% ± 18% | |
type II pneumocyte | 3 studies | 26% ± 8% | |
pancreatic A cell | 3 studies | 41% ± 11% | |
club cell | 3 studies | 22% ± 7% | |
basal cell | 3 studies | 32% ± 8% | |
adipocyte | 3 studies | 26% ± 13% | |
myoepithelial cell | 3 studies | 47% ± 10% | |
ependymal cell | 3 studies | 48% ± 16% | |
melanocyte | 3 studies | 28% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 21439.43 | 652 / 653 | 89% | 282.63 | 539 / 605 |
brain | 86% | 3896.86 | 2269 / 2642 | 99% | 421.46 | 698 / 705 |
ovary | 84% | 5522.91 | 152 / 180 | 90% | 164.08 | 389 / 430 |
breast | 97% | 5139.48 | 443 / 459 | 30% | 24.49 | 330 / 1118 |
bladder | 95% | 3703.00 | 20 / 21 | 26% | 21.08 | 129 / 504 |
kidney | 55% | 1602.71 | 49 / 89 | 64% | 58.27 | 581 / 901 |
skin | 72% | 8363.16 | 1307 / 1809 | 39% | 25.70 | 186 / 472 |
prostate | 76% | 2526.49 | 187 / 245 | 35% | 16.31 | 174 / 502 |
uterus | 83% | 3665.55 | 141 / 170 | 27% | 20.26 | 126 / 459 |
lung | 89% | 3287.98 | 515 / 578 | 21% | 11.10 | 238 / 1155 |
esophagus | 88% | 3126.20 | 1266 / 1445 | 13% | 6.59 | 23 / 183 |
blood vessel | 100% | 16641.71 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 42.43 | 1 / 1 |
adipose | 99% | 7118.26 | 1189 / 1204 | 0% | 0 | 0 / 0 |
stomach | 61% | 1402.90 | 218 / 359 | 9% | 3.44 | 26 / 286 |
heart | 49% | 3375.00 | 419 / 861 | 0% | 0 | 0 / 0 |
spleen | 44% | 1016.05 | 106 / 241 | 0% | 0 | 0 / 0 |
pancreas | 17% | 347.55 | 55 / 328 | 19% | 6.57 | 34 / 178 |
intestine | 24% | 567.24 | 234 / 966 | 11% | 4.32 | 60 / 527 |
tonsil | 0% | 0 | 0 / 0 | 18% | 7.26 | 8 / 45 |
adrenal gland | 6% | 150.34 | 16 / 258 | 9% | 5.47 | 20 / 230 |
eye | 0% | 0 | 0 / 0 | 11% | 5.12 | 9 / 80 |
liver | 1% | 17.89 | 2 / 226 | 4% | 1.90 | 15 / 406 |
muscle | 1% | 30.37 | 9 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
GO_0048715 | Biological process | negative regulation of oligodendrocyte differentiation |
GO_0021766 | Biological process | hippocampus development |
GO_0045444 | Biological process | fat cell differentiation |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0048712 | Biological process | negative regulation of astrocyte differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0048708 | Biological process | astrocyte differentiation |
GO_0022010 | Biological process | central nervous system myelination |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0045665 | Biological process | negative regulation of neuron differentiation |
GO_0060741 | Biological process | prostate gland stromal morphogenesis |
GO_0060740 | Biological process | prostate gland epithelium morphogenesis |
GO_0030154 | Biological process | cell differentiation |
GO_0061682 | Biological process | seminal vesicle morphogenesis |
GO_0008104 | Biological process | protein localization |
GO_0021895 | Biological process | cerebral cortex neuron differentiation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0007405 | Biological process | neuroblast proliferation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0140110 | Molecular function | transcription regulator activity |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ID4 |
Protein name | DNA-binding protein inhibitor ID-4 (Class B basic helix-loop-helix protein 27) (bHLHb27) (Inhibitor of DNA binding 4) (Inhibitor of differentiation 4) |
Synonyms | BHLHB27 |
Description | FUNCTION: Transcriptional regulator (lacking a basic DNA binding domain) which negatively regulates the basic helix-loop-helix (bHLH) transcription factors by forming heterodimers and inhibiting their DNA binding and transcriptional activity. Implicated in regulating a variety of cellular processes, including cellular growth, senescence, differentiation, apoptosis, angiogenesis, and neoplastic transformation (By similarity). . |
Accessions | P47928 ENST00000378700.8 |